US Food and Drug Administration regulatory updates in neuro-oncology-Reference-Cited by-同舟云学术

US Food and Drug Administration regulatory updates in neuro-oncology

Published:2021-06-22 Issue:3 Volume:153 Page:375-381
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Mehta Gautam U.^ORCID,Barone Amy K.,Bradford Diana,Larkins Erin,Kim Janice,Pai-Scherf Lee,Jaigirdar Adnan,Shah Mirat,Wedam Suparna,Amiri-Kordestani Laleh,Theoret Marc R.,Pazdur Richard,Beaver Julia A.,Singh Harpreet

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Neurology,Neurology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11060-021-03789-5.pdf

Reference35 articles.

1. Zhou J, Vallejo J, Kluetz P, Pazdur R, Kim T, Keegan P, Farrell A, Beaver JA, Sridhara R (2019) Overview of oncology and hematology drug approvals at US Food and Drug Administration between 2008 and 2016. J Natl Cancer Inst 111:449–458

2. US Food and Drug Administration (2020) Oncology center of excellence 2020 annual report.

3. Amiri-Kordestani L, Pazdur R (2021) Oncology approvals in 2020: a year of firsts in the midst of a pandemic. Nat Rev Clin Oncol 18:2020–2021

4. Huson SM, Compston DA, Harper PS (1989) A genetic study of von Recklinghausen neurofibromatosis in south east Wales. II. Guidelines for genetic counselling. J Med Genet 26:712–721

5. Friedman JM (1999) Epidemiology of neurofibromatosis type 1. Am J Med Genet - Semin Med Genet 89:1–6

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of giant neurofibromas in extremities and trunk wall of neurofibromatosis type 1 patients: a Chinese 12‐year single‐institution experience;ANZ Journal of Surgery;2024-05-31

2. 7-Azaindole, 2,7-diazaindole, and 1H-pyrazole as core structures for novel anticancer agents with potential chemosensitizing properties;European Journal of Medicinal Chemistry;2022-10

3. Novel Clinical Trial Designs in Neuro-Oncology;Neurotherapeutics;2022-08-15

4. Extending Our Reach: Expanding Enrollment in Brain Metastases and Primary Brain Tumor Clinical Trials;American Society of Clinical Oncology Educational Book;2022-07

5. RET receptor signaling: Function in development, metabolic disease, and cancer;Proceedings of the Japan Academy, Series B;2022-03-11